MedTrace Logo

Non-motor Symptoms and Brain Dopamine Transporter Binding

NCT02650843 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 455

Last updated 2025-04-13

No results posted yet for this study

Summary

This project aims to clarify the role non-motor symptoms in the development of Parkinson's disease (PD) and to improve diagnostics at very early stages of PD. The project involves multidimensional measures of disease biomarkers together with brain dopamine transporter (DAT) imaging with \[123I\]FP-CIT single photon emission computed tomography (SPECT).

Conditions

  • Parkinson Disease
  • Parkinsonism

Interventions

OTHER

DAT SPECT imaging

Sponsors & Collaborators

  • Helsinki University Central Hospital

    collaborator OTHER

  • Turku University Hospital

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2026-12-31
Completion
2026-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02650843 on ClinicalTrials.gov